UnitedHealth Group Incorporated (UNH) Holdings Maintained by Hussman Strategic Advisors Inc.
Hussman Strategic Advisors Inc. held its position in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,000 shares of the healthcare conglomerate’s stock at the close of the second quarter. Hussman Strategic Advisors Inc.’s holdings in UnitedHealth Group were worth $4,636,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the company. Northstar Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 15.9% in the second quarter. Northstar Wealth Partners LLC now owns 1,665 shares of the healthcare conglomerate’s stock worth $311,000 after purchasing an additional 228 shares during the period. Davis R M Inc. increased its stake in shares of UnitedHealth Group by 9.2% in the second quarter. Davis R M Inc. now owns 2,470 shares of the healthcare conglomerate’s stock worth $458,000 after purchasing an additional 208 shares during the period. Beach Investment Management LLC. bought a new position in shares of UnitedHealth Group in the second quarter worth about $556,000. WealthTrust Axiom LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $203,000. Finally, Founders Financial Securities LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $213,000. Institutional investors and hedge funds own 86.19% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) opened at 198.06 on Friday. UnitedHealth Group Incorporated has a one year low of $133.03 and a one year high of $200.76. The stock has a 50 day moving average price of $196.36 and a 200 day moving average price of $183.56. The firm has a market capitalization of $191.50 billion, a P/E ratio of 23.79 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.96 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
A number of equities analysts have recently commented on the company. Barclays PLC lifted their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 19th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target on the stock in a research note on Thursday, September 21st. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. Finally, Jefferies Group LLC restated a “buy” rating and set a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Three analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $203.59.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last three months, insiders sold 76,174 shares of company stock worth $14,981,909. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.